Targanta Therapeutics to Present at November 2008 Investor Conferences
November 05 2008 - 7:58AM
Business Wire
Targanta Therapeutics Corporation (Nasdaq: TARG) today announced
its planned participation in the following investor conferences in
November 2008: Rodman and Renshaw 10th Annual Healthcare Conference
on Tuesday, November 11, 2008 at 5:45p.m. ET at the New York Palace
Hotel in New York, NY. Credit Suisse 2008 Healthcare Conference on
Friday, November 14, 2008 at 12:00p.m. ET at the Arizona Biltmore
in Phoenix, AZ. Lazard Capital Markets 5th Annual Healthcare
Conference on Tuesday, November 18, 2008 at 2:40p.m. ET at the St.
Regis Hotel in New York, NY. The presentations will be webcast live
and will be available for replay for approximately 30 days
following the presentations through the Investor Relations section
of Targanta�s website at www.targanta.com/investors. About Targanta
Therapeutics Targanta Therapeutics Corporation (Nasdaq: TARG) is a
biopharmaceutical company focused on developing and commercializing
innovative antibiotics to treat serious infections in the hospital
and other institutional settings. The Company�s pipeline includes
an intravenous version of oritavancin, a semi-synthetic
lipoglycopeptide antibiotic currently awaiting U.S. and EU
regulatory approval, and, a program to develop an oral version of
oritavancin for the treatment of Clostridium difficile. The Company
has operations in Cambridge, MA, Indianapolis, IN, and Montreal,
Qu�bec, Canada. For more information on Targanta, visit
www.targanta.com.
Targanta Therapeutics Corp (MM) (NASDAQ:TARG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Targanta Therapeutics Corp (MM) (NASDAQ:TARG)
Historical Stock Chart
From Jul 2023 to Jul 2024